Psychometric properties evaluation of the Persian version of the self-report outcome scale for lupus disease Lupus

Abstract

Purpose

Systemic Lupus Erythematosus (SLE) significantly affects both the quality of life related to health and non-health aspects. This study aims to evaluate the psychometric properties of the Persian version of the Lupus_PRO questionnaire, version 1.7. The questionnaire serves as a specific self-report outcome scale for assessing the treatment outcomes of Lupus disease.

Methods

The Lupus_PRO questionnaire, version 1.7, was translated into Persian using the standard forward-backward method. After being completed by 218 patients with Lupus, the psychometric properties of the instrument were examined. The Convergent and Discriminant Validity of the scale were assessed using Average Variance Extracted and Cross Loadings, respectively. The construct validity of the questionnaire was also evaluated through Confirmatory Factor Analysis (CFA). Cronbach’s alpha was calculated to assess the reliability of the questionnaire dimensions.

Findings

Out of the 218 patients with lupus who participated in the current study, 13 (6%) were male, and 205 (94%) were female. The mean (SD) age of participants was 40.29 (10.94) years. The Average Variance Extracted (AVE) for HRQOL and Non-HRQOL constructs, except for the Coping and Cognition dimension, was greater than 0.50, indicating satisfactory convergent validity. The interdimensional correlation coefficient (Discriminant Validity) for each dimension with other questionnaire dimensions was less than 0.10, indicating that the questionnaire has good convergent and discriminant validity. Additionally, the results of the Confirmatory Factor Analysis (CFA) indicated that the questionnaire was a suitable fit. In terms of reliability, Cronbach’s alpha for the various questionnaire dimensions ranged from 0.51 to 0.91, indicating good internal consistency.

Conclusion

The Persian version of the Lupus_PRO questionnaire, version 1.7, demonstrates acceptable validity and reliability in the Iranian population. This instrument can effectively measure various aspects of the quality of life in patients with lupus.

Keywords

Get full access to this article

View all access options for this article.

References

Holloway

Humphrey

Heron

, et al. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. Health Qual Life Outcome 2014; 12: 116.

Elera-Fitzcarrald

Fuentes

González

, et al. Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions. Expet Rev Clin Immunol 2018; 14(11): 915–931.

Elkaraly

Nasef

Omar

, et al. The Arabic LupusPRO: a cross-cultural validation of a disease-specific patient-reported outcome tool for quality of life in lupus patients. Lupus 2020; 29(13): 1727–1735.

Jolly

Pickard

Block

, et al. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum 2012; 42(1): 56–65.

Jolly

Toloza

Block

, et al. Spanish LupusPRO: cross-cultural validation study for lupus. Lupus 2013; 22(5): 431–436.

Mahieu

Yount

Ramsey-Goldman

. Patient-reported outcomes in systemic lupus erythematosus. Rheum Dis Clin N Am 2016; 42(2): 253–263.

Dua

Touma

Toloza

, et al. Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus. Curr Rheumatol Rep 2013; 15(12): 380.

Hosseini

Bonakdar

Gholamrezaei

, et al. Evaluating the validity and reliability of Persian version of Lupus Quality of Life (LupusQol) questionnaire in Iranian patients. Journal of Isfahan Medical School 2013; 31(260): 1836–1847.

Gladman

Ibañez

Urowitz

. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29(2): 288–291.

10.

Rahman

Gladman

Urowitz

, et al. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001; 10(2): 93–96.

11.

Montazeri

Goshtasebi

Vahdaninia

, et al. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 2005; 14: 875–882.

12.

Bullinger

Alonso

Apolone

, et al. Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51(11): 913–923.

13.

Gliem

(eds). Calculating, interpreting, and reporting Cronbach’s alpha reliability coefficient for Likert-type scales. In: 2003 Midwest Research to Practice Conference in Adult, Continuing, and Community Education, Columbus, Ohio, 2003.

14.

Mok

Kosinski

, et al. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus. Arthritis Care Res 2015; 67(2): 297–304.

15.

Kernder

Elefante

Chehab

, et al.

The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?

Rheumatology 2020; 59(Suppl5): v63–v68.

16.

Kaya

Goker

Cura

, et al. Turkish lupusPRO: cross-cultural validation study for lupus. Clin Rheumatol 2014; 33(8): 1079–1084.

17.

Inoue

Shiozawa

Yoshihara

, et al. The Japanese LupusPRO: a cross-cultural validation of an outcome measure for lupus. Lupus 2017; 26(8): 849–856.

18.

Rutter

Kiemle

. Exploring the social and interpersonal experiences of south asian women with a diagnosis of systemic lupus erythematosus. Psychol Health 2015; 30(3): 318–335.

Psychometric properties evaluation of the Persian version of the self-report outcome scale for lupus disease Lupus_PRO version 1.7